Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

Lupin Launches Additional Strengths of Generic Lotrel® Capsules

July 6, 2011 9:36 am | by Bio-Medicine.Org | News | Comments

BALTIMORE, July 6, 2011 /- Lupin Pharmaceuticals, Inc. (LPI) announced today that the U.S. Food and Drug Administration (US FDA) has granted final approval for its Amlodipine / Benazepril 5mg/40mg, and 10mg/40mg capsules.  Commercial shipments of the product have already commenced....

Potential Mechanism of Action Identified for the Treatment of Major Depression With Trigeminal Nerve Stimulation (TNS) - The USB Port to the Brainâ„¢

July 5, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES, July 5, 2011 /- NeuroSigma, a Los Angeles-based neuromodulation company, today announced that a recent Phase I clinical trial revealed that external Trigeminal Nerve Stimulation (eTNS™) increased regional cerebral blood flow in brain regions associated with depression...

Acute Coronary Syndrome (ACS) Drug Market

July 5, 2011 4:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, July 5, 2011 /- announces that a new market research report is available in its catalogue: Acute Coronary Syndrome (ACS) Drug Market ...


Wireless Technology Now Allows Diabetes Patients to Manage Their Disease Real-Time and On-the-Go

June 30, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

DALLAS, June 30, 2011 /- According to the Centers for Disease Control and Prevention, nearly 26 million adults and children in the United States -- or 8.3 percent of the population -- have diabetes. Imagine if this sizeable group was able to more easily manage their diabetes while at...

Stem Cell Assurance Announces the Launch of its Brown Fat Stem Cell Therapeutic and Cosmetic Platform Technology Program

June 30, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

JUPITER, Fla., June 30, 2011 /- Stem Cell Assurance, Inc. (SCLZ.PK ) ("SCA") today announced the launch of a platform technology that involves the use of brown fat for cell-based therapeutic/cosmetic purposes.  Through its brown fat program, SCA intends to develop treatments for...

Boston Scientific Announces U.S. and European Launch of Interlockâ„¢ - 35 Fibered IDCâ„¢ Occlusion System

June 30, 2011 4:34 am | by Boston Scientific | News | Comments

Detachable coils for peripheral embolization offer precise placement and control in coiling procedures

Golden Meditech FY2010-11 Annual Results

June 30, 2011 2:34 am | by Bio-Medicine.Org | News | Comments

HONG KONG, June 30, 2011 /PRNewswire-Asia-FirstCall/ -- Golden Meditech Holdings Limited ("Golden Meditech," together with its subsidiaries collectively as the "Group," - 801.HK; 910801.TW), a leading integrated healthcare enterprise in China, is pleased to announce the Group's annual...

FDA Consumer Health Information - FDA's MedWatch Safety Alerts: May 2011

June 28, 2011 10:36 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., June 28, 2011 /PRNewswire-USNewswire/ -- The Food and Drug Administration (FDA) has recently issued safety alerts about a number of products, including: (Logo: ) birth control pills that may increase the risk of blood...


New Study Shows Viability of Heart Pumps for Older Heart-Failure Patients

June 28, 2011 10:35 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, June 28, 2011 /- Results of a clinical research study at Sharp Memorial Hospital indicate that patients 70 years of age or older have good functional recovery, survival and quality of life at two years when undergoing left ventricular assist device (LVAD) therapy for heart...

InfraReDx rounds up $24M in new funding

June 28, 2011 5:32 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Burlington-based medical device firm InfraReDx Inc. said it has raised $24.1 million in a new equity offering, seven months after completing a $21 million equity round.

New Arrivals of Exercise & Health Care Equipment

June 27, 2011 11:32 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, June 27, 2011 /PRNewswire-Asia/ -- Shenzhen Wuzhou Changlian International Trading Co., a leading online distributor specializing in health care electronics & medical equipment, announces its new arrivals of exercise equipment and health care electronics, which have...

BioDrain Streamway® System Receives Positive Evaluations on Two Additional Units

June 27, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, June 27, 2011 /- BioDrain Medical, Inc. (OTCBB: BIOR, OTCQB: BIOR), producer of the FDA cleared Streamway® System for automated surgical fluid disposal, today announced that it has placed two additional units and that new evaluations are underway at surgical facilities...

Dr. Jay Yadav, CardioMEMS Founder & CEO, Named Ernst & Young Entrepreneur of the Year®

June 27, 2011 8:33 am | by Bio-Medicine.Org | News | Comments

ATLANTA, June 27, 2011 /- CardioMEMS, Inc ., an Atlanta-based medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body, today announced that its founder and CEO, Jay Yadav, M.D. , has been honored with...


Omeros Unlocks Orphan GPCRs Linked to Leukemia and Sleep Disorders

June 27, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

SEATTLE, June 27, 2011 /- Omeros Corporation (NASDAQ: OMER ) today reported that it has identified compounds that interact with orphan G protein-coupled receptors (GPCRs) P2Y8 and OPN4. P2Y8 (also known as P2RY8) is associated with acute lymphoblastic leukemia (ALL), an aggressive cancer...

Cellular Dynamics International Unlocks the Potential of Banked Blood Samples

June 27, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

MADISON, Wis., June 27, 2011 /- Cellular Dynamics International (CDI) today announced the online publication of an article in the journal Blood demonstrating for the first time a methodology for researchers to access the biology stored in repositories of banked blood samples through the...

ERA-EDTA Congress 2011: Late Breaking Clinical Trials II

June 25, 2011 7:32 am | by Bio-Medicine.Org | News | Comments

PRAGUE, June 25, 2011 /-   The SHARP-study has shown that lowering LDL cholesterol with ezetimibe/simvastatinleads to a significant reduction in major atherosclerotic events among CKD-patients. Whether it also has a favourable effect on renal disease progression was another of the...

Linagliptin recommended for approval in the treatment of type 2 diabetes in Europe

June 24, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

RIDGEFIELD, Conn. and INDIANAPOLIS, June 24, 2011 /- Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY ) today received a positive opinion from the European Medicines Agency's (EMA) medicinal committee recommending approval of linagliptin, 5 mg, film-coated tablets (to be marketed...

Ceramic Replaces Titanium With Machining Assistance

June 22, 2011 9:55 am | by Klaus A. Burckhardt, PE | Articles | Comments

Coated titanium was to be replaced as the material for the stator housing in a right ventrical assist device. Zirconia ceramic was the material selected and expert machining met the needs for very tight tolerances to fabricate the component.

CardioGenics Transfers Magnetic Beads Business Unit Into its Luxspheres Inc. Subsidiary

June 22, 2011 6:42 am | by Bio-Medicine.Org | News | Comments

MISSISSAUGA, Ontario, June 22, 2011 /- CardioGenics Holdings Inc. (CGNH.OB) announced today the transfer of its magnetic beads business unit, which develops ultra sensitive magnetic beads for use in diagnostic devices, into its Canadian subsidiary, Luxspheres Inc. The beads business unit,...

Cardium Announces Cedars-Sinai Heart Institute as the SPECT Imaging Core Lab for the Recently Announced Generx® Phase 3 Clinical Registration Study in the Russian Federation

June 22, 2011 6:42 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, June 22, 2011 /- Cardium Therapeutics (NYSE Amex: CXM ) today announced the selection of the Cedars-Sinai Medical Center Nuclear Cardiology Core Laboratory (Cedars-Sinai Core Laboratory), Los Angeles, California, to serve as the central core lab for the Company’s Generx...

Alzheimer's Drug Discovery Foundation Supports Axxam To Develop Novel Therapeutics for Alzheimer's Disease

June 22, 2011 6:41 am | by Bio-Medicine.Org | News | Comments

NEW YORK , June 22, 2011 /PRNewswire-USNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it has awarded a grant to Axxam SpA to develop small molecules to treat Alzheimer's disease by targeting inflammation. (Logo:...

iHealth Lab's Blood Pressure Self-Monitoring System Gets Nationwide Distribution

June 22, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 22, 2011 /- (Digital Experience!) -- iHealth Lab Inc., the pioneering designer and manufacturer of digital personal healthcare products including the iHealth BP3 Blood Pressure Monitoring System for iPhone, iPod touch and iPad, today announced that multiple national retail...

Chinmax Disclaims Liability Following China SFDA's Confirmation that Inverness Medical Beijing is Suspected of Forging SFDA Verification Seal and Approval Date in Submission o...

June 21, 2011 7:44 am | by Bio-Medicine.Org | News | Comments

BEIJING, June 21, 2011 /PRNewswire-Asia/ -- Chinmax Medical Systems Inc. , a leading cardiac biomarker distributor in China, announced today that it disclaims all liability in connection with an official letter it received from the China State Food and Drug Administration (SFDA) on June...


June 21, 2011 3:39 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, SAN DIEGO and WALTHAM, Mass., June 21, 2011 /- Eli Lilly and Company (NYSE: LLY ), together with Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) and Alkermes, Inc. (Nasdaq: ALKS ), announced today that the European Commission has granted marketing authorization to...

FDA Issues Draft Guidance for Early Version of an Artificial Pancreas System

June 20, 2011 9:41 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., June 20, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today issued draft guidance that will help advance the development and approval of an artificial pancreas system to treat type 1 diabetes in the United States. (Logo:  ...

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.